COVID-19(8) SARS-CoV-2.(7) HIV(6) antiviral therapy(5) advent(3) combination therapy(3) protease inhibitors(3) regulatory agency(3) Medicine(3) provided(3) hepatitis B(3) small molecule(3) Long-ActingAntivirals(3) SARS-CoV-2(3) combination therapies(3) molnupiravir(3) Each(3) Infection(3) monoclonal antibodies(3) Prevent(3) Prophylaxis(3) classical(3) early treatment(3) severe COVID-19 disease(3) manifestation(3) Antiviral(3) landscape(3) monoclonal antibody(3) polymerase(3) protease(3)